Teyro Labs
India 191 employees 2 duplicate records merged Updated 9 July 2026
Teyro Labs is a finished-dose manufacturer based in India. It appears in 5 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by CDSCO (India), US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 12 November 2025 as VAI.
4
registered plants
1 with an FDA FEI number
5
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 12 November 2025 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| kancheepuram 601 301, India | Not on file |
| Kancheepuram, India | Not on file |
| Chennai, India | Not on file |
| Kanchipuram District, India | 3021389808 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 5 | 1 |
| CDSCO (India) | None | 2 |
| EMA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Teyro Labs comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 12 November 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates